Highlights Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-12 pm EDT			5-day change	1st Jan Change
3.810 ^USD	-0.26%		-0.52%	+136.65%

Jun. 10	Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program	RE
Jun. 02	Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes	RE

Highlights

Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 06	CI
Neuronetics, Inc. Revises Earnings Guidance for the Full Year 2025	May. 06	CI
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025	May. 06	CI
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4	Mar. 27	RE
Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025	Mar. 04	CI
Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	Mar. 04	CI
Neuronetics Seeks Acquisitions	Feb. 07	CI
Neuronetics Prices Eight Million Share Offering at $2.25 Per Share	Feb. 07	MT
Neuronetics, Inc. Unveils Two Significant Publications on TMS Therapy for Depression	Jan. 29	CI
Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	Jan. 13	CI
Neuronetics, Inc. completed the acquisition of Greenbrook TMS Inc. (OTCPK:GBNH.F) from Madryn Health Partners II (Cayman Feeder), LP, fund managed by Madryn Asset Management, LP, 1315 Capital II, L.P. fund managed by 1315 Capital, LLC, Greybrook Health Inc. and others for $0.58 million.	Dec. 08	CI
Earnings Flash (STIM) NEURONETICS Reports Q3 Revenue $18.5M	Nov. 12	MT
Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 12	CI
Neuronetics, Inc. Provides Standalone Earnings Guidance for the Fourth Quarter and Full Year 2024	Nov. 12	CI
Neuronetics, Greenbrook Receive Interim Order for Special Meeting of Shareholders for Greenbrook	24-10-04	MT
Neuronetics, Inc. Expands Health Policies Enhance Tms Therapy Access for Adolescents and Adults	24-09-19	CI
Neuronetics Shares Slump as Q2 Results Fall Below Estimates; Merger Announcement	24-08-12	MT
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	24-08-12	CI
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.5M, vs. Street Est of $18.7M	24-08-12	MT
Neuronetics, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024	24-08-12	CI
Neuronetics, Inc. entered into a definitive arrangement agreement to acquire Greenbrook TMS Inc. (OTCPK:GBNH.F) from Madryn Health Partners II (Cayman Feeder), LP, fund managed by Madryn Asset Management, LP and others for $1 million.	24-08-11	CI
Neuronetics, Inc. Announces Aetna Policy Update Expands TMS Availability for Adolescents with Depression	24-07-22	CI
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents	24-05-15	CI
Earnings Flash (STIM) NEURONETICS Reports Q1 Revenue $17.4M	24-05-07	MT
Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-05-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Highlights

Filters